510(k) Report

510(k) · Cleared

Cleared

Fotona Dualis ND:Yag Laser System, Fotona Twinlight ND:Yag Laser System

K013047510(k) TraditionalCleared Dec 6, 200187-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mojca Valijavec · GEX Powered Laser Surgical Instrument

Cleared on Dec 6, 2001 as substantially equivalent to K010834 (Laserscope, 2001) and 1 other predicate after an 87-day review. Its family tree reaches back 1 generation to 2001.

Decided
Dec 6, 2001
Review
87 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K003202 (2001). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK003202 · Family of Altus Medical Coolglide Aesthetic Lasers, Models I & II · Altus Medical · 200120002002
Other ancestors, by generation 1 generation back: 1 other ancestor K003202 · Family of Altus Medical Coolglide Aesthetic Lasers, Models I & II · Altus Medical · 20010
  1. Root · 1 generation backK003202 Family of Altus Medical Coolglide Aesthetic Lasers, Models I & IIAltus Medical · 2001
  2. This deviceK013047 Fotona Dualis ND:Yag Laser System, Fotona Twinlight ND:Yag Laser…Mojca Valijavec · 2001
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K003202Family of Altus Medical Coolglide Aesthetic Lasers, Models I & IIAltus Medical2001—
0 (this device)K013047Fotona Dualis ND:Yag Laser System, Fotona Twinlight ND:Yag Laser SystemMojca Valijavec2001—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K013047, 2001–2001Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010834Lyra Series Surgical Laser System & Accessories
Summary page 1
…nce The family of Fotona DUALIS lasers shares the same general indications for use, and therefore is substantially equivalent to the currently marketed Laserscope Lyra (K010834) and to Altus Medical Aesthetic Nd:YAG Laser (K003202). 510(k) Submission: Family of Fotona DUALIS Nd:YAG Lasers Pagc 18 === Pa…
Laserscope2001—
*K003202Family of Altus Medical Coolglide Aesthetic Lasers, Models I & II
Summary page 1
…e general indications for use, and therefore is substantially equivalent to the currently marketed Laserscope Lyra (K010834) and to Altus Medical Aesthetic Nd:YAG Laser (K003202). 510(k) Submission: Family of Fotona DUALIS Nd:YAG Lasers Pagc 18 Technologically, the predicate devices have s…
Altus Medical2001—

Also cleared against K010834: 7 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 7 other devices also cite its predicate K010834.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The family of Fotona DUALIS Nd:YAG laser systems is indicated for use in surgical and aesthetic applications requiring selective photothermolysis of target chromophores in soft tissue in the medical specialities of general and plastic surgery and dermatology: . To effect stable long-term, or permanent, hair reduction in skin types I - VI through selective targeting of melanin in hair folliclcs. Permanent hair reduction is defined as a long-term stable…

Read the full statement (128 words)

The family of Fotona DUALIS Nd:YAG laser systems is indicated for use in surgical and aesthetic applications requiring selective photothermolysis of target chromophores in soft tissue in the medical specialities of general and plastic surgery and dermatology:

. To effect stable long-term, or permanent, hair reduction in skin types I - VI through selective targeting of melanin in hair folliclcs. Permanent hair reduction is defined as a long-term stable reduction in the number of hairs regrowing after a trcatment regimen.

. For rcmoval of unwanted hair.

. For coagulation and hemostasis of vascular lesions.

. For incision/excision of soft body tissue in dermatology

. For soft tissue general surgery applications - skin incision; tissue dissection; complete or partial resection of intcrnal organs, tumors, lesions; tissue ablation; vessel coagulation

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K013047: Fotona Dualis ND:Yag Laser System, Fotona Twinlight ND:Yag Laser System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K013047

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026